Shopping Cart
- Remove All
- Your shopping cart is currently empty
PSI-697 is an inhibitor of oral P-selectin (IC50: 125 μM).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.729 € | 1-2 weeks | |
50 mg | 2.261 € | 1-2 weeks | |
100 mg | 2.945 € | 1-2 weeks | |
1 mL x 10 mM (in DMSO) | 264 € | 1-2 weeks |
Description | PSI-697 is an inhibitor of oral P-selectin (IC50: 125 μM). |
Targets&IC50 | P-selectin:125 μM |
In vitro | PSI-697 inhibits the binding of a soluble human P-selectin to PSGL-1. In vitro, as a reproducible concentration-dependent manner inhibiting 50% of binding at a concentration of 125 μM [1]. |
In vivo | PSI-697 (30 mg/kg; p.o.; daily; 6 days) promotes thrombus resolution and reduces inflammation in a baboon model of venous thrombosis. PSI-697 ((30 mg/kg; i.g.; daily) decreases vein wall injury in a rat stenosis model of venous thrombosis. PSI-697 (100 mg/kg; p.o.) reduces thrombus weight by 18% relative to the vehicle, without prolonging bleeding time in a rat venous thrombosis model. PSI-697 (0-50 mg/kg; p.o.) obviously decreases the number of rolling leukocytes by 39% versus vehicle control[1][2]. |
Alias | P-Selectin Inhibitor |
Molecular Weight | 367.83 |
Formula | C21H18ClNO3 |
Cas No. | 851546-61-7 |
Relative Density. | 1.383 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 45.8 mg/mL (124.51 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.